A multi-centre, open, investigator initiated phase IV clinical trial to evaluate the efficacy and safety of ingenol mebutate gel, 0.015% on the face and scalp, and 0.05% on the trunk and extremities, in Korean patients with actinic keratosis (PERFECT).
| Author | |
|---|---|
| Abstract |
:
Ingenol mebutate gel is a novel, field-directed topical treatment for actinic keratosis (AK). Most pivotal studies have targeted Western populations. No clinical study has been conducted to investigate its efficacy and safety in Asian populations. |
| Year of Publication |
:
2018
|
| Journal |
:
The British journal of dermatology
|
| Date Published |
:
2018
|
| ISSN Number |
:
0007-0963
|
| URL |
:
http://dx.doi.org/10.1111/bjd.16368
|
| DOI |
:
10.1111/bjd.16368
|
| Short Title |
:
Br J Dermatol
|
| Download citation |
